Microbot Medical Inc.
$2.3
▲
1.27%
2026-04-21 08:04:00
microbotmedical.com
NCM: MBOT
Explore Microbot Medical Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$154.46 M
Current Price
$2.3
52W High / Low
$4.67 / $1.6
Stock P/E
—
Book Value
$1.16
Dividend Yield
—
ROCE
-18.87%
ROE
-32.42%
Face Value
—
EPS
$-0.29
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
43
Beta
1.19
Debt / Equity
1.11
Current Ratio
23.33
Quick Ratio
23.16
Forward P/E
-7.85
Price / Sales
—
Enterprise Value
$96.21 M
EV / EBITDA
-6.55
EV / Revenue
—
Rating
None
Target Price
$7.5
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | OraSure Technologies, Inc. | $3.19 | — | $221.2 M | — | -18.75% | -18.3% | $3.82 / $2.08 | $4.84 |
| 2. | Harvard Bioscience, Inc. | $6.99 | — | $30.92 M | — | 0.17% | -1.47% | $9.46 / $2.81 | $3.07 |
| 3. | AtriCure, Inc. | $28.79 | — | $1.51 B | — | -1.65% | -2.4% | $43.18 / $27.26 | $9.88 |
| 4. | Align Technology, Inc. | $194.19 | 34.46 | $14 B | — | 13.57% | 10.39% | $208.31 / $122 | $56.74 |
| 5. | Bausch + Lomb Corporation | $16.76 | — | $5.94 B | — | 1.55% | -5.39% | $18.91 / $10.45 | $18.2 |
| 6. | AptarGroup, Inc. | $125.33 | 21.29 | $8.05 B | 1.47% | 12.5% | 15.1% | $164.28 / $103.23 | $41.56 |
| 7. | Femasys Inc. | $0.42 | — | $25.6 M | — | -460.52% | -4.56% | $1.29 / $0.31 | $0.1 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 0 M | 0 M | 0 M | 0 M | 0 M | — |
| Operating Profit | -4.14 M | -3.86 M | -3.72 M | -3.02 M | -3.43 M | — |
| Net Profit | -3.46 M | -3.58 M | -3.5 M | -2.6 M | -3.39 M | — |
| EPS in Rs | -0.05 | -0.05 | -0.05 | -0.04 | -0.05 | -0.2 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 0 M | 0 M | 0 M | 0 M |
| Operating Profit | -14.74 M | -11.62 M | -10.14 M | -13.44 M |
| Net Profit | -13.14 M | -11.44 M | -10.74 M | -13.17 M |
| EPS in Rs | -0.2 | -0.17 | -0.16 | -0.2 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 81.54 M | 6.03 M | 8.33 M | 9.54 M |
| Total Liabilities | 3.99 M | 2.5 M | 3.83 M | 2.25 M |
| Equity | 77.55 M | 3.53 M | 4.5 M | 7.29 M |
| Current Assets | 79.82 M | 5.82 M | 7.92 M | 8.81 M |
| Current Liabilities | 3.42 M | 2.46 M | 3.79 M | 2.07 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -13.05 M | -8.83 M | -8.53 M | -11.55 M |
| Investing CF | -72.38 M | 1.54 M | 1.97 M | -3.84 M |
| Financing CF | 86.24 M | 7.94 M | 6.56 M | 4.32 M |
| Free CF | -13.11 M | -8.85 M | -8.57 M | -11.63 M |
| Capex | -0.06 M | -0.03 M | -0.03 M | -0.08 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | — | — | — | — |
| Earnings Growth % | -6.55% | 18.44% | — | — |
| Profit Margin % | — | — | — | — |
| Operating Margin % | — | — | — | — |
| Gross Margin % | — | — | — | — |
| EBITDA Margin % | — | — | — | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.